user-avatar
CNBC TV18

Akums Drugs Q2 Results: Profit nearly triples, EBITDA doubles on strong CDMO growth

Akums Drugs reported a 177% jump in Q2 net profit, with revenue rising 32%. Strong CDMO growth and improved operating margins supported the pharmaceutical manufacturer's performance.